Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001779706 | SCV002015465 | uncertain significance | not provided | 2022-09-08 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV002489828 | SCV002775078 | uncertain significance | Polycystic kidney disease 3 with or without polycystic liver disease | 2021-07-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002544235 | SCV003728485 | uncertain significance | Inborn genetic diseases | 2022-04-07 | criteria provided, single submitter | clinical testing | The c.992G>A (p.R331H) alteration is located in exon 10 (coding exon 10) of the GANAB gene. This alteration results from a G to A substitution at nucleotide position 992, causing the arginine (R) at amino acid position 331 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |